The information below is intended only to provide the recommendations and rationale from the Committee to Evaluate Drugs (CED) and the Executive Officer decisions regarding the listing of products on the Formulary or the New Drug Funding Program for cancer care.

Do not rely upon any of the information provided on this site for medical diagnosis or treatment. Please consult your primary health care provider about any personal health concerns. This website does not provide any medical diagnosis, symptom assessment, health counseling or medical opinion for individual users. The information contained on this site is intended for information purposes only and does not constitute medical advice for patients. For more detailed information on prescription drugs, please consult a qualified healthcare professional.

List alphabetically

BRAND NAME	GENERIC NAME	DATE PUBLISHED
AUGUST 2008
Alimta – non-small cell lung cancer	pemetrexed	August 2008
Aromasin – early breast cancer	exemestane	August 2008
Azilect	rasagiline	August 2008
Gemzar – metastatic breast cancer	gemcitabine hydrochloride	August 2008
Hycamtin – small cell lung cancer	topotecan	August 2008
Kaletra	lopinavir/ritonavir	August 2008
MabCampath	alemtuzumab	August 2008
Trosec	trospium chloride	August 2008
Xeloda – gastric cancer	capecitabine	August 2008
JUNE 2008
Altace HCT	ramipril/hydrochlorothiazide	June 2008
Aricept RDT	donepezil rapidly dissolving tablet	June 2008
Denavir	penciclovir	June 2008
Exjade	deferasirox	June 2008
Lucentis	ranibizumab	June 2008
Truvada	emtricitabine/tenofovir disoproxil fumarate	June 2008
Tysabri	natalizumab	June 2008
MAY 2008
Alvesco	ciclesonide	May 2008
DDAVP Melt	desmopressin	May 2008
Elaprase	idursulfase	May 2008
Hypurin	insulin porcine	May 2008
Revatio	sildenafil	May 2008
Sutent – MRCC	sunitinib	May 2008
JANUARY 2008
Prezista	darunavir	January 2008
Linessa	desogestrel/ethinyl estradiol	January 2008
Yasmin	drospirenone/ethinyl estradiol	January 2008
Femara	letrozole	January 2008
Altace 15mg capsule	ramipril 15mg capsule	January 2008
Rituxan	rituximab	January 2008
OCTOBER 2007
Duragesic 12	fentanyl 12.5mcg/hr transdermal patch	October 2007
Altace Plus Felodipine	ramipril/felodipine	October 2007
Avalide	irbesartan/hydrochlorothiazide	October 2007
Caelyx – recurrent ovarian cancer	pegylated liposomal doxorubicin	October 2007
Cipralex	escitalopram	October 2007
Humira – psoriatic arthritis	adalimumab	October 2007
Hycamtin – recurrent ovarian cancer	topotecan	October 2007
Sutent – GIST	sunitinib	October 2007
Taxol – recurrent ovarian cancer	paclitaxel	October 2007
Vfend	voriconazole	October 2007
JULY 2007
Actonel Plus Calcium	risedronate sodium/calcium carbonate	July 2007
Alimta - MPM	pemetrexed	July 2007
Diovan	valsartan	July 2007
Enablex	darifenacin	July 2007
Fosavance	alendronate/cholecalciferol	July 2007
Gleevec - CML	imatinib mesylate	July 2007
Gleevec - GIST	imatinib mesylate	July 2007
OxyContin	oxycodone hydrochloride	July 2007
To view PDF format files, you need to have Adobe Acrobat® Reader installed on your computer.    You can download this free software from the Adobe website.